The phrase "analyzed for efficacy" is correct and usable in written English.
You can use it in contexts where you are discussing the evaluation or assessment of the effectiveness of a treatment, intervention, or product.
Example: "The new medication was analyzed for efficacy in clinical trials to determine its potential benefits for patients."
Alternatives: "evaluated for effectiveness" or "assessed for performance".
Data from 393 and 398 patients were analyzed for efficacy and safety, respectively.
Patients receiving ≥1 dose of study drug were analyzed for safety (safety analysis set), and patients in the safety analysis set who had ≥1 post-baseline IDS-C30 efficacy assessment were analyzed for efficacy (full analysis set).
The D+/R− group was separately analyzed for efficacy.
In the aim to understand if the overall sample size analyzed for efficacy (Total N = 1,410) would be large enough to detect a potential significant valganciclovir advantage, we calculated the power needed to detect valganciclovir superiority based on a 7% reduction of CMV disease (12% to 5%), as suggested in the original trial by Paya et al. [7].
In the highest dose cohort, 18 patients who completed treatment per protocol were analyzed for efficacy.
All patients were analyzed for efficacy and safety with an intention-to-treat analysis.
Material and Method: 50 patients with sensorineural tinnitus were divided into two groups: 25 received acamprosate and 25 placebo, for a period of 3 months, in a prospective double-blind study, being analyzed for its efficacy and safety by the subjective score from 1 to 10 given by the patient.
Therefore, 13 patients were analyzed for clinical efficacy.
The population analyzed for all efficacy and safety endpoints was the modified intent-to-treat population, which comprised all randomized patients who received at least one dose of study treatment.
Next, tumor-specific CTLs were stimulated with CD3 mAb in the presence of a co-stimulation signal (CD28 mAb) or with the cognate Ag (tumor cells) and analyzed for tumor rejection efficacy in vivo.
In 736 patients, the drugs were analyzed for toxicity and efficacy.
